

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | epoxygenase P450 pathway (GO:0019373) | 7.92252751 |
| 2 | exogenous drug catabolic process (GO:0042738) | 7.78828202 |
| 3 | omega-hydroxylase P450 pathway (GO:0097267) | 7.62932259 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.45117314 |
| 5 | L-phenylalanine catabolic process (GO:0006559) | 7.45117314 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.12880537 |
| 7 | L-phenylalanine metabolic process (GO:0006558) | 7.12880537 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.65127355 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.61665905 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 6.15003479 |
| 11 | glucuronate metabolic process (GO:0019585) | 6.07818559 |
| 12 | uronic acid metabolic process (GO:0006063) | 6.07818559 |
| 13 | glyoxylate metabolic process (GO:0046487) | 6.03606033 |
| 14 | tryptophan catabolic process (GO:0006569) | 5.99996539 |
| 15 | indole-containing compound catabolic process (GO:0042436) | 5.99996539 |
| 16 | indolalkylamine catabolic process (GO:0046218) | 5.99996539 |
| 17 | drug metabolic process (GO:0017144) | 5.98946434 |
| 18 | oxidative demethylation (GO:0070989) | 5.96916178 |
| 19 | kynurenine metabolic process (GO:0070189) | 5.93679648 |
| 20 | regulation of fibrinolysis (GO:0051917) | 5.91085310 |
| 21 | high-density lipoprotein particle remodeling (GO:0034375) | 5.84746504 |
| 22 | regulation of protein activation cascade (GO:2000257) | 5.81311985 |
| 23 | bile acid biosynthetic process (GO:0006699) | 5.77641672 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.66973825 |
| 25 | protein carboxylation (GO:0018214) | 5.63921847 |
| 26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.63921847 |
| 27 | tryptophan metabolic process (GO:0006568) | 5.63115369 |
| 28 | urea cycle (GO:0000050) | 5.61656553 |
| 29 | urea metabolic process (GO:0019627) | 5.61656553 |
| 30 | alpha-linolenic acid metabolic process (GO:0036109) | 5.47370267 |
| 31 | regulation of humoral immune response (GO:0002920) | 5.34445522 |
| 32 | cysteine metabolic process (GO:0006534) | 5.32830194 |
| 33 | regulation of complement activation (GO:0030449) | 5.32309814 |
| 34 | reverse cholesterol transport (GO:0043691) | 5.26462205 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 5.24857821 |
| 36 | phenylpropanoid metabolic process (GO:0009698) | 5.21469396 |
| 37 | nitrogen cycle metabolic process (GO:0071941) | 5.15698871 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 5.11877404 |
| 39 | plasma lipoprotein particle remodeling (GO:0034369) | 5.08211128 |
| 40 | protein-lipid complex remodeling (GO:0034368) | 5.08211128 |
| 41 | macromolecular complex remodeling (GO:0034367) | 5.08211128 |
| 42 | regulation of triglyceride catabolic process (GO:0010896) | 5.05580966 |
| 43 | serine family amino acid catabolic process (GO:0009071) | 5.03805819 |
| 44 | bile acid metabolic process (GO:0008206) | 4.95759284 |
| 45 | ethanol metabolic process (GO:0006067) | 4.92114176 |
| 46 | negative regulation of hemostasis (GO:1900047) | 4.87813640 |
| 47 | negative regulation of blood coagulation (GO:0030195) | 4.87813640 |
| 48 | phospholipid efflux (GO:0033700) | 4.82347675 |
| 49 | aromatic amino acid family metabolic process (GO:0009072) | 4.81931088 |
| 50 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.81682240 |
| 51 | acylglycerol homeostasis (GO:0055090) | 4.78032375 |
| 52 | triglyceride homeostasis (GO:0070328) | 4.78032375 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.70722765 |
| 54 | plasma lipoprotein particle clearance (GO:0034381) | 4.60760739 |
| 55 | homocysteine metabolic process (GO:0050667) | 4.56530085 |
| 56 | negative regulation of complement activation (GO:0045916) | 4.54457967 |
| 57 | negative regulation of cholesterol transport (GO:0032375) | 4.52071888 |
| 58 | negative regulation of sterol transport (GO:0032372) | 4.52071888 |
| 59 | amino-acid betaine metabolic process (GO:0006577) | 4.50766728 |
| 60 | alpha-amino acid catabolic process (GO:1901606) | 4.49212109 |
| 61 | negative regulation of coagulation (GO:0050819) | 4.48159571 |
| 62 | cellular ketone body metabolic process (GO:0046950) | 4.47271010 |
| 63 | cholesterol efflux (GO:0033344) | 4.46529660 |
| 64 | hormone catabolic process (GO:0042447) | 4.42159379 |
| 65 | lysine metabolic process (GO:0006553) | 4.39895187 |
| 66 | lysine catabolic process (GO:0006554) | 4.39895187 |
| 67 | fibrinolysis (GO:0042730) | 4.33901139 |
| 68 | glycine metabolic process (GO:0006544) | 4.31054870 |
| 69 | S-adenosylmethionine metabolic process (GO:0046500) | 4.30274487 |
| 70 | alkaloid metabolic process (GO:0009820) | 4.29851963 |
| 71 | blood coagulation, intrinsic pathway (GO:0007597) | 4.24731486 |
| 72 | bile acid and bile salt transport (GO:0015721) | 4.23424421 |
| 73 | indolalkylamine metabolic process (GO:0006586) | 4.22748650 |
| 74 | coenzyme catabolic process (GO:0009109) | 4.21781066 |
| 75 | * negative regulation of wound healing (GO:0061045) | 4.21414126 |
| 76 | plasma lipoprotein particle assembly (GO:0034377) | 4.20256782 |
| 77 | imidazole-containing compound metabolic process (GO:0052803) | 4.16182362 |
| 78 | glutamate metabolic process (GO:0006536) | 4.14896425 |
| 79 | negative regulation of protein activation cascade (GO:2000258) | 4.14689406 |
| 80 | cellular biogenic amine catabolic process (GO:0042402) | 4.13582748 |
| 81 | amine catabolic process (GO:0009310) | 4.13582748 |
| 82 | cellular amino acid catabolic process (GO:0009063) | 4.12549082 |
| 83 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.11497052 |
| 84 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.11497052 |
| 85 | * acute-phase response (GO:0006953) | 4.09398700 |
| 86 | serine family amino acid metabolic process (GO:0009069) | 4.07278515 |
| 87 | aldehyde catabolic process (GO:0046185) | 4.04032899 |
| 88 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03301134 |
| 89 | protein activation cascade (GO:0072376) | 4.02253400 |
| 90 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.01182779 |
| 91 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.01182779 |
| 92 | benzene-containing compound metabolic process (GO:0042537) | 4.00440708 |
| 93 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.00179998 |
| 94 | flavonoid metabolic process (GO:0009812) | 3.99997371 |
| 95 | positive regulation of hemostasis (GO:1900048) | 3.99646314 |
| 96 | positive regulation of blood coagulation (GO:0030194) | 3.99646314 |
| 97 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.99581499 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.98891175 |
| 99 | arginine metabolic process (GO:0006525) | 3.98185510 |
| 100 | serine family amino acid biosynthetic process (GO:0009070) | 3.97532220 |
| 101 | cellular glucuronidation (GO:0052695) | 3.96488440 |
| 102 | cellular modified amino acid catabolic process (GO:0042219) | 3.95803395 |
| 103 | complement activation (GO:0006956) | 3.93487860 |
| 104 | opsonization (GO:0008228) | 3.90369138 |
| 105 | heme transport (GO:0015886) | 3.87293745 |
| 106 | plasma lipoprotein particle organization (GO:0071827) | 3.87077058 |
| 107 | ketone body metabolic process (GO:1902224) | 3.86917007 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.86135608 |
| 109 | positive regulation of lipid catabolic process (GO:0050996) | 3.84702205 |
| 110 | * acute inflammatory response (GO:0002526) | 3.83628861 |
| 111 | negative regulation of lipase activity (GO:0060192) | 3.83485167 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.79089701 |
| 113 | cofactor catabolic process (GO:0051187) | 3.77626425 |
| 114 | protein-lipid complex assembly (GO:0065005) | 3.76117788 |
| 115 | cytolysis (GO:0019835) | 3.74000293 |
| 116 | ethanol oxidation (GO:0006069) | 3.73196087 |
| 117 | regulation of plasminogen activation (GO:0010755) | 3.73139036 |
| 118 | sterol homeostasis (GO:0055092) | 3.72835144 |
| 119 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.70547177 |
| 120 | positive regulation of coagulation (GO:0050820) | 3.67205159 |
| 121 | drug catabolic process (GO:0042737) | 3.65012382 |
| 122 | protein-lipid complex subunit organization (GO:0071825) | 3.63588592 |
| 123 | carboxylic acid catabolic process (GO:0046395) | 3.61818567 |
| 124 | organic acid catabolic process (GO:0016054) | 3.61818567 |
| 125 | regulation of cholesterol homeostasis (GO:2000188) | 3.60892045 |
| 126 | regulation of apoptotic cell clearance (GO:2000425) | 3.60048916 |
| 127 | negative regulation of humoral immune response (GO:0002921) | 3.60006895 |
| 128 | daunorubicin metabolic process (GO:0044597) | 3.59542920 |
| 129 | polyketide metabolic process (GO:0030638) | 3.59542920 |
| 130 | doxorubicin metabolic process (GO:0044598) | 3.59542920 |
| 131 | * regulation of acute inflammatory response (GO:0002673) | 3.59423805 |
| 132 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.58100163 |
| 133 | steroid catabolic process (GO:0006706) | 3.55269904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.30038508 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13325758 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.96960267 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.44259624 |
| 5 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.33308126 |
| 6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.24541840 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.89562003 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.14928755 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.08294107 |
| 10 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03746750 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.00281735 |
| 12 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 12.2071730 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.94960489 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.90004804 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.63807682 |
| 16 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.51922743 |
| 17 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.50911783 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48829089 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.47242862 |
| 20 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39989174 |
| 21 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.26098714 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.25316826 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.25300845 |
| 24 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.19880680 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.17990749 |
| 26 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98511476 |
| 27 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.97471602 |
| 28 | * CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.95235668 |
| 29 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.91968079 |
| 30 | * GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.91849818 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.90389462 |
| 32 | * HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.88894514 |
| 33 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.88780446 |
| 34 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.87712038 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85795473 |
| 36 | * PHF8_20622853_ChIP-Seq_HELA_Human | 0.85615031 |
| 37 | * GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.82656982 |
| 38 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.82332373 |
| 39 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82137502 |
| 40 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.81925438 |
| 41 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.81716617 |
| 42 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.78534101 |
| 43 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.77099614 |
| 44 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.76478345 |
| 45 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.76284155 |
| 46 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.75675950 |
| 47 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.73032762 |
| 48 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.72487808 |
| 49 | * NFYA_21822215_ChIP-Seq_K562_Human | 0.70508509 |
| 50 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70276151 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69838494 |
| 52 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.69329009 |
| 53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.69263644 |
| 54 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.68848096 |
| 55 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.68834713 |
| 56 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.67574644 |
| 57 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.67511301 |
| 58 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66097098 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.65686883 |
| 60 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.65542633 |
| 61 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65377006 |
| 62 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.64586475 |
| 63 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.62392679 |
| 64 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62082912 |
| 65 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.61938527 |
| 66 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.61938527 |
| 67 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.61646832 |
| 68 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.61431402 |
| 69 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.61389836 |
| 70 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.60649092 |
| 71 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.60381972 |
| 72 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.59793350 |
| 73 | * CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.59308607 |
| 74 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.58267836 |
| 75 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.58104982 |
| 76 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.57827968 |
| 77 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.57555357 |
| 78 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.57487129 |
| 79 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.57290030 |
| 80 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.56322200 |
| 81 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.55745617 |
| 82 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.55542125 |
| 83 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.55235230 |
| 84 | * RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.55127953 |
| 85 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.54618399 |
| 86 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.54618239 |
| 87 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.54502938 |
| 88 | * ETV1_20927104_ChIP-Seq_GIST48_Human | 0.53674751 |
| 89 | * CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.53507550 |
| 90 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.53241984 |
| 91 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.52374643 |
| 92 | AR_20517297_ChIP-Seq_VCAP_Human | 0.52241196 |
| 93 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51889801 |
| 94 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51188955 |
| 95 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.51110406 |
| 96 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.50839967 |
| 97 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.50415306 |
| 98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.50211762 |
| 99 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.50166785 |
| 100 | * ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.50108222 |
| 101 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.49232717 |
| 102 | SA1_27219007_Chip-Seq_Bcells_Human | 0.48803959 |
| 103 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.48536047 |
| 104 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.48279019 |
| 105 | GATA1_19941826_ChIP-Seq_K562_Human | 0.48193955 |
| 106 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.47905179 |
| 107 | * NFYB_21822215_ChIP-Seq_K562_Human | 0.47773110 |
| 108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.46227021 |
| 109 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.45871694 |
| 110 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45480245 |
| 111 | CBP_21632823_ChIP-Seq_H3396_Human | 0.45439957 |
| 112 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.45030132 |
| 113 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44813562 |
| 114 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.44175196 |
| 115 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.43784690 |
| 116 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43274207 |
| 117 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.42940652 |
| 118 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.42488300 |
| 119 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.41590642 |
| 120 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.40933309 |
| 121 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.40699756 |
| 122 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.40635637 |
| 123 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.39942338 |
| 124 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.39699092 |
| 125 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.39062070 |
| 126 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.37832509 |
| 127 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.37813341 |
| 128 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.37675770 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.37427794 |
| 130 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.36420386 |
| 131 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.36329006 |
| 132 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.35098520 |
| 133 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.34907851 |
| 134 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34835225 |
| 135 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.34125806 |
| 136 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.34111485 |
| 137 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.34007022 |
| 138 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.33999574 |
| 139 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.33011273 |
| 140 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.32864413 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.08501498 |
| 2 | MP0005360_urolithiasis | 7.59336826 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.35950457 |
| 4 | MP0005365_abnormal_bile_salt | 6.04081336 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.84925290 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.24420821 |
| 7 | MP0003252_abnormal_bile_duct | 3.80281279 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.67498212 |
| 9 | MP0009840_abnormal_foam_cell | 3.47322076 |
| 10 | MP0005083_abnormal_biliary_tract | 3.18748241 |
| 11 | MP0003191_abnormal_cellular_cholesterol | 2.96892150 |
| 12 | MP0003195_calcinosis | 2.87513569 |
| 13 | MP0005332_abnormal_amino_acid | 2.71820651 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.56930171 |
| 15 | MP0000609_abnormal_liver_physiology | 2.20741418 |
| 16 | MP0002118_abnormal_lipid_homeostasis | 2.11295617 |
| 17 | MP0004019_abnormal_vitamin_homeostasis | 2.08683379 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.01582745 |
| 19 | MP0003868_abnormal_feces_composition | 1.84850425 |
| 20 | MP0005319_abnormal_enzyme/_coenzyme | 1.81792527 |
| 21 | MP0001764_abnormal_homeostasis | 1.63261239 |
| 22 | MP0009697_abnormal_copulation | 1.59217589 |
| 23 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.57892176 |
| 24 | MP0003011_delayed_dark_adaptation | 1.54978535 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.43854012 |
| 26 | MP0005451_abnormal_body_composition | 1.35923781 |
| 27 | MP0009643_abnormal_urine_homeostasis | 1.22620230 |
| 28 | MP0003705_abnormal_hypodermis_morpholog | 1.22050227 |
| 29 | MP0003186_abnormal_redox_activity | 1.21785680 |
| 30 | MP0000598_abnormal_liver_morphology | 1.21776075 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.18457080 |
| 32 | MP0002254_reproductive_system_inflammat | 1.15324998 |
| 33 | MP0005647_abnormal_sex_gland | 1.11945874 |
| 34 | MP0009764_decreased_sensitivity_to | 1.11771409 |
| 35 | MP0009763_increased_sensitivity_to | 1.09716585 |
| 36 | MP0005636_abnormal_mineral_homeostasis | 0.97902923 |
| 37 | MP0008469_abnormal_protein_level | 0.95766143 |
| 38 | MP0009642_abnormal_blood_homeostasis | 0.90724302 |
| 39 | MP0005187_abnormal_penis_morphology | 0.86722318 |
| 40 | MP0005408_hypopigmentation | 0.83202718 |
| 41 | MP0009765_abnormal_xenobiotic_induced | 0.82140160 |
| 42 | MP0001915_intracranial_hemorrhage | 0.82133123 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.81389255 |
| 44 | * MP0000604_amyloidosis | 0.80411101 |
| 45 | MP0005670_abnormal_white_adipose | 0.79642293 |
| 46 | MP0006036_abnormal_mitochondrial_physio | 0.77993483 |
| 47 | MP0002078_abnormal_glucose_homeostasis | 0.77566757 |
| 48 | MP0005220_abnormal_exocrine_pancreas | 0.76363635 |
| 49 | MP0005084_abnormal_gallbladder_morpholo | 0.75001740 |
| 50 | MP0002282_abnormal_trachea_morphology | 0.74162064 |
| 51 | MP0003690_abnormal_glial_cell | 0.73225688 |
| 52 | MP0005464_abnormal_platelet_physiology | 0.72782836 |
| 53 | MP0002876_abnormal_thyroid_physiology | 0.72089698 |
| 54 | MP0002971_abnormal_brown_adipose | 0.72085743 |
| 55 | MP0001661_extended_life_span | 0.71440688 |
| 56 | MP0009053_abnormal_anal_canal | 0.70954256 |
| 57 | MP0003879_abnormal_hair_cell | 0.70457358 |
| 58 | MP0000639_abnormal_adrenal_gland | 0.67442776 |
| 59 | MP0005334_abnormal_fat_pad | 0.65847223 |
| 60 | MP0005535_abnormal_body_temperature | 0.64850478 |
| 61 | MP0004130_abnormal_muscle_cell | 0.64229587 |
| 62 | MP0010386_abnormal_urinary_bladder | 0.63039726 |
| 63 | MP0003329_amyloid_beta_deposits | 0.61356280 |
| 64 | MP0005266_abnormal_metabolism | 0.61205502 |
| 65 | MP0001756_abnormal_urination | 0.58613126 |
| 66 | MP0005448_abnormal_energy_balance | 0.55834512 |
| 67 | MP0006035_abnormal_mitochondrial_morpho | 0.53602693 |
| 68 | MP0002089_abnormal_postnatal_growth/wei | 0.53455380 |
| 69 | MP0005058_abnormal_lysosome_morphology | 0.53452230 |
| 70 | MP0003436_decreased_susceptibility_to | 0.52685359 |
| 71 | MP0003724_increased_susceptibility_to | 0.50642061 |
| 72 | MP0002249_abnormal_larynx_morphology | 0.50495349 |
| 73 | MP0003075_altered_response_to | 0.47085031 |
| 74 | MP0003638_abnormal_response/metabolism_ | 0.46855276 |
| 75 | MP0008873_increased_physiological_sensi | 0.45270382 |
| 76 | MP0002822_catalepsy | 0.44741364 |
| 77 | MP0005166_decreased_susceptibility_to | 0.44238721 |
| 78 | MP0003718_maternal_effect | 0.43747016 |
| 79 | MP0004883_abnormal_blood_vessel | 0.43567544 |
| 80 | MP0008874_decreased_physiological_sensi | 0.42601913 |
| 81 | MP0002928_abnormal_bile_duct | 0.42155620 |
| 82 | * MP0002136_abnormal_kidney_physiology | 0.41735301 |
| 83 | MP0002837_dystrophic_cardiac_calcinosis | 0.40613185 |
| 84 | MP0000579_abnormal_nail_morphology | 0.40079662 |
| 85 | * MP0005395_other_phenotype | 0.39305038 |
| 86 | MP0003953_abnormal_hormone_level | 0.39295985 |
| 87 | MP0000249_abnormal_blood_vessel | 0.37898258 |
| 88 | MP0005666_abnormal_adipose_tissue | 0.37852139 |
| 89 | MP0005248_abnormal_Harderian_gland | 0.36710990 |
| 90 | MP0004782_abnormal_surfactant_physiolog | 0.36455262 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.35929981 |
| 92 | MP0005164_abnormal_response_to | 0.35739908 |
| 93 | MP0002796_impaired_skin_barrier | 0.35253585 |
| 94 | MP0008872_abnormal_physiological_respon | 0.34163924 |
| 95 | MP0006082_CNS_inflammation | 0.33917197 |
| 96 | MP0002168_other_aberrant_phenotype | 0.33443366 |
| 97 | MP0000467_abnormal_esophagus_morphology | 0.33048470 |
| 98 | MP0001243_abnormal_dermal_layer | 0.32354468 |
| 99 | MP0009672_abnormal_birth_weight | 0.32261655 |
| 100 | MP0009115_abnormal_fat_cell | 0.31895026 |
| 101 | MP0004381_abnormal_hair_follicle | 0.31106115 |
| 102 | MP0002132_abnormal_respiratory_system | 0.30723088 |
| 103 | MP0005023_abnormal_wound_healing | 0.30708250 |
| 104 | MP0002090_abnormal_vision | 0.30581852 |
| 105 | * MP0001845_abnormal_inflammatory_respons | 0.30020839 |
| 106 | MP0000230_abnormal_systemic_arterial | 0.29956668 |
| 107 | MP0002332_abnormal_exercise_endurance | 0.29941519 |
| 108 | MP0002970_abnormal_white_adipose | 0.29198234 |
| 109 | MP0001881_abnormal_mammary_gland | 0.29117548 |
| 110 | MP0001853_heart_inflammation | 0.27462455 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.27231900 |
| 112 | MP0003300_gastrointestinal_ulcer | 0.26805148 |
| 113 | * MP0009785_altered_susceptibility_to | 0.24943022 |
| 114 | MP0000920_abnormal_myelination | 0.23082292 |
| 115 | MP0001944_abnormal_pancreas_morphology | 0.22905278 |
| 116 | MP0000566_synostosis | 0.20900140 |
| 117 | MP0003959_abnormal_lean_body | 0.20864019 |
| 118 | MP0001851_eye_inflammation | 0.18388083 |
| 119 | MP0001545_abnormal_hematopoietic_system | 0.18255196 |
| 120 | MP0005397_hematopoietic_system_phenotyp | 0.18255196 |
| 121 | MP0002128_abnormal_blood_circulation | 0.16277913 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 7.68306956 |
| 2 | Intrahepatic cholestasis (HP:0001406) | 7.20440899 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.17462381 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.87365612 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44423191 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 6.34120399 |
| 7 | Xanthomatosis (HP:0000991) | 6.28669922 |
| 8 | Complement deficiency (HP:0004431) | 5.80424332 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.73017056 |
| 10 | Abnormality of the common coagulation pathway (HP:0010990) | 5.20596945 |
| 11 | Joint hemorrhage (HP:0005261) | 5.11189736 |
| 12 | Hypolipoproteinemia (HP:0010981) | 4.97911369 |
| 13 | Hypoalphalipoproteinemia (HP:0003233) | 4.56893197 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.54811408 |
| 15 | Hyperammonemia (HP:0001987) | 4.52153831 |
| 16 | Epidermoid cyst (HP:0200040) | 4.34387115 |
| 17 | Abnormality of complement system (HP:0005339) | 4.25594297 |
| 18 | Hyperglycinemia (HP:0002154) | 4.21689495 |
| 19 | Abnormality of methionine metabolism (HP:0010901) | 4.20358790 |
| 20 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.16079720 |
| 21 | Spontaneous abortion (HP:0005268) | 4.13462137 |
| 22 | Ketosis (HP:0001946) | 4.13121341 |
| 23 | Fat malabsorption (HP:0002630) | 4.06612028 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.06580136 |
| 25 | Abnormality of the intrinsic pathway (HP:0010989) | 3.99272279 |
| 26 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.93630144 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.78977175 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.66628681 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.65571130 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.65571130 |
| 31 | Hyperglycinuria (HP:0003108) | 3.60429083 |
| 32 | Conjugated hyperbilirubinemia (HP:0002908) | 3.58720355 |
| 33 | Hypercholesterolemia (HP:0003124) | 3.50567069 |
| 34 | Hyperbilirubinemia (HP:0002904) | 3.28679339 |
| 35 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.21750673 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.17964001 |
| 37 | Hypochromic microcytic anemia (HP:0004840) | 3.08846741 |
| 38 | Steatorrhea (HP:0002570) | 3.03430411 |
| 39 | Hepatocellular carcinoma (HP:0001402) | 3.03245821 |
| 40 | Systemic lupus erythematosus (HP:0002725) | 2.96669952 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.93871079 |
| 42 | Abnormality of nucleobase metabolism (HP:0010932) | 2.92762124 |
| 43 | Abnormality of serum amino acid levels (HP:0003112) | 2.91523378 |
| 44 | Amyloidosis (HP:0011034) | 2.89938796 |
| 45 | Myocardial infarction (HP:0001658) | 2.88341652 |
| 46 | Ketoacidosis (HP:0001993) | 2.87342281 |
| 47 | Gingival bleeding (HP:0000225) | 2.86313247 |
| 48 | Glomerulonephritis (HP:0000099) | 2.78042333 |
| 49 | Metabolic acidosis (HP:0001942) | 2.70093032 |
| 50 | Skin nodule (HP:0200036) | 2.69620379 |
| 51 | Reduced antithrombin III activity (HP:0001976) | 2.66362493 |
| 52 | Osteomalacia (HP:0002749) | 2.64471794 |
| 53 | Purpura (HP:0000979) | 2.61903050 |
| 54 | Acanthocytosis (HP:0001927) | 2.60122143 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.56552938 |
| 56 | Abnormality of purine metabolism (HP:0004352) | 2.55828846 |
| 57 | Lethargy (HP:0001254) | 2.51957722 |
| 58 | Vascular calcification (HP:0004934) | 2.48025356 |
| 59 | Thrombophlebitis (HP:0004418) | 2.47782995 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.46413993 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.46413993 |
| 62 | Abnormal gallbladder morphology (HP:0012437) | 2.42950008 |
| 63 | Gout (HP:0001997) | 2.42250138 |
| 64 | Spastic diplegia (HP:0001264) | 2.41513301 |
| 65 | Fair hair (HP:0002286) | 2.40286801 |
| 66 | Hypoglycemic seizures (HP:0002173) | 2.39622427 |
| 67 | Cholelithiasis (HP:0001081) | 2.39298043 |
| 68 | Menorrhagia (HP:0000132) | 2.33985582 |
| 69 | Cerebral edema (HP:0002181) | 2.33952494 |
| 70 | Mitral stenosis (HP:0001718) | 2.30851674 |
| 71 | Cholecystitis (HP:0001082) | 2.30050186 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.30050186 |
| 73 | Neonatal onset (HP:0003623) | 2.28932244 |
| 74 | Irritability (HP:0000737) | 2.28633735 |
| 75 | Esophageal varix (HP:0002040) | 2.24916935 |
| 76 | Malnutrition (HP:0004395) | 2.22062467 |
| 77 | Neonatal hypoglycemia (HP:0001998) | 2.21316205 |
| 78 | Cardiovascular calcification (HP:0011915) | 2.20058797 |
| 79 | Pancreatitis (HP:0001733) | 2.16903499 |
| 80 | Sensorimotor neuropathy (HP:0007141) | 2.12194579 |
| 81 | Enlarged kidneys (HP:0000105) | 2.10090871 |
| 82 | Elevated alkaline phosphatase (HP:0003155) | 2.07460006 |
| 83 | Poikilocytosis (HP:0004447) | 2.07088465 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.05031083 |
| 85 | Vomiting (HP:0002013) | 2.03665191 |
| 86 | Late onset (HP:0003584) | 2.02879262 |
| 87 | Increased serum ferritin (HP:0003281) | 2.02758404 |
| 88 | Hemorrhage of the eye (HP:0011885) | 1.99989104 |
| 89 | Hyperphosphaturia (HP:0003109) | 1.99243025 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.99238357 |
| 91 | Abnormality of the Achilles tendon (HP:0005109) | 1.97597270 |
| 92 | Abnormality of the gallbladder (HP:0005264) | 1.97262388 |
| 93 | Brushfield spots (HP:0001088) | 1.96882093 |
| 94 | Generalized aminoaciduria (HP:0002909) | 1.96741882 |
| 95 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93981159 |
| 96 | Opisthotonus (HP:0002179) | 1.93790546 |
| 97 | Arthropathy (HP:0003040) | 1.92585828 |
| 98 | Nephritis (HP:0000123) | 1.91983599 |
| 99 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.90441780 |
| 100 | Rickets (HP:0002748) | 1.84054220 |
| 101 | Gangrene (HP:0100758) | 1.82246371 |
| 102 | Glycosuria (HP:0003076) | 1.82193281 |
| 103 | Abnormality of urine glucose concentration (HP:0011016) | 1.82193281 |
| 104 | Joint swelling (HP:0001386) | 1.81748825 |
| 105 | Elevated hepatic transaminases (HP:0002910) | 1.80789021 |
| 106 | Abnormal delivery (HP:0001787) | 1.79711157 |
| 107 | Cerebral palsy (HP:0100021) | 1.79630153 |
| 108 | Hypophosphatemic rickets (HP:0004912) | 1.78858741 |
| 109 | Pulmonary embolism (HP:0002204) | 1.77764155 |
| 110 | Abnormality of vitamin metabolism (HP:0100508) | 1.77485827 |
| 111 | Status epilepticus (HP:0002133) | 1.76204951 |
| 112 | Abnormal cartilage morphology (HP:0002763) | 1.75185726 |
| 113 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.74844599 |
| 114 | Hypertriglyceridemia (HP:0002155) | 1.73690769 |
| 115 | Renal cortical cysts (HP:0000803) | 1.73343115 |
| 116 | Potter facies (HP:0002009) | 1.72836217 |
| 117 | Facial shape deformation (HP:0011334) | 1.72836217 |
| 118 | Atrioventricular block (HP:0001678) | 1.71796499 |
| 119 | Epistaxis (HP:0000421) | 1.68840248 |
| 120 | Generalized hypopigmentation of hair (HP:0011358) | 1.68301842 |
| 121 | Alkalosis (HP:0001948) | 1.68124668 |
| 122 | Hydroxyprolinuria (HP:0003080) | 1.67571276 |
| 123 | Abnormality of proline metabolism (HP:0010907) | 1.67571276 |
| 124 | Abnormal urine phosphate concentration (HP:0012599) | 1.60019827 |
| 125 | Bile duct proliferation (HP:0001408) | 1.55436405 |
| 126 | Abnormal biliary tract physiology (HP:0012439) | 1.55436405 |
| 127 | Increased serum pyruvate (HP:0003542) | 1.48124760 |
| 128 | Bifid scrotum (HP:0000048) | 1.46098733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.22984574 |
| 2 | LMTK2 | 6.78099053 |
| 3 | ERN1 | 5.27891646 |
| 4 | FGFR4 | 4.84304996 |
| 5 | SIK1 | 3.93287612 |
| 6 | ERBB4 | 3.04011635 |
| 7 | TAOK3 | 3.03416623 |
| 8 | INSRR | 2.76642503 |
| 9 | MAP4K2 | 2.46159956 |
| 10 | MAP2K4 | 2.33178537 |
| 11 | MST1R | 2.15625876 |
| 12 | NTRK3 | 2.08846139 |
| 13 | TRIB3 | 2.06309211 |
| 14 | MAPK11 | 1.99137083 |
| 15 | PKN2 | 1.95116485 |
| 16 | PIK3CA | 1.90719383 |
| 17 | PIK3CG | 1.86858713 |
| 18 | TYK2 | 1.84044444 |
| 19 | FLT3 | 1.65572026 |
| 20 | PTK6 | 1.61153626 |
| 21 | DAPK2 | 1.58316309 |
| 22 | LATS1 | 1.57919803 |
| 23 | PRKG2 | 1.55764237 |
| 24 | NEK9 | 1.48868255 |
| 25 | TNK2 | 1.45752165 |
| 26 | FER | 1.43615102 |
| 27 | ABL2 | 1.40252379 |
| 28 | KDR | 1.38262333 |
| 29 | JAK2 | 1.29109070 |
| 30 | EPHB1 | 1.26646376 |
| 31 | EPHA3 | 1.25559533 |
| 32 | FRK | 1.24749142 |
| 33 | FGFR2 | 1.20135108 |
| 34 | GRK6 | 1.16221758 |
| 35 | PRPF4B | 1.15281648 |
| 36 | PRKG1 | 1.13468246 |
| 37 | CAMKK2 | 1.13380771 |
| 38 | ERBB2 | 1.12630883 |
| 39 | MAP3K7 | 1.11509964 |
| 40 | JAK1 | 1.09681180 |
| 41 | MAP2K3 | 1.08252506 |
| 42 | TBK1 | 1.06454745 |
| 43 | PRKAA2 | 1.02860620 |
| 44 | PINK1 | 1.01804223 |
| 45 | MAPK4 | 0.96742489 |
| 46 | MAP3K10 | 0.93585202 |
| 47 | NLK | 0.91686733 |
| 48 | MET | 0.90828552 |
| 49 | ZAP70 | 0.89823416 |
| 50 | MAP3K2 | 0.88671971 |
| 51 | MAP3K11 | 0.88431961 |
| 52 | PDK2 | 0.86976659 |
| 53 | MAP3K3 | 0.86375893 |
| 54 | PRKCZ | 0.85938960 |
| 55 | EIF2AK3 | 0.85910601 |
| 56 | MYLK | 0.83503496 |
| 57 | MAP3K14 | 0.83147337 |
| 58 | PRKACA | 0.82975244 |
| 59 | MAPK12 | 0.80243775 |
| 60 | PRKACG | 0.79366391 |
| 61 | TIE1 | 0.79149309 |
| 62 | MAP3K12 | 0.77604602 |
| 63 | CDK6 | 0.75877287 |
| 64 | CAMK2G | 0.73191845 |
| 65 | MAPKAPK3 | 0.72583462 |
| 66 | RIPK1 | 0.72546454 |
| 67 | CSNK1D | 0.68806293 |
| 68 | STK38L | 0.67164056 |
| 69 | GSK3A | 0.66992940 |
| 70 | CSK | 0.63865234 |
| 71 | FGFR3 | 0.63434459 |
| 72 | DYRK1B | 0.62387581 |
| 73 | SCYL2 | 0.61795340 |
| 74 | TGFBR2 | 0.61525966 |
| 75 | CAMKK1 | 0.61158197 |
| 76 | PRKAA1 | 0.59381862 |
| 77 | CAMK1D | 0.57043994 |
| 78 | MAPK15 | 0.56702467 |
| 79 | PTK2 | 0.56002347 |
| 80 | MAP2K6 | 0.55635866 |
| 81 | CSF1R | 0.54725546 |
| 82 | MAPK7 | 0.54115146 |
| 83 | SGK3 | 0.52865573 |
| 84 | PDPK1 | 0.50995119 |
| 85 | IKBKE | 0.49979524 |
| 86 | PKN1 | 0.47653364 |
| 87 | SRC | 0.46905421 |
| 88 | PRKCQ | 0.46089931 |
| 89 | BLK | 0.45959523 |
| 90 | MAP2K1 | 0.45218949 |
| 91 | RPS6KA3 | 0.44909219 |
| 92 | MAP3K5 | 0.43790756 |
| 93 | RET | 0.43036485 |
| 94 | PRKCG | 0.42280860 |
| 95 | IRAK3 | 0.40705241 |
| 96 | GRK1 | 0.40186669 |
| 97 | EPHA4 | 0.39731837 |
| 98 | IGF1R | 0.38843496 |
| 99 | CSNK2A1 | 0.38339580 |
| 100 | CDK4 | 0.37946467 |
| 101 | TAOK2 | 0.37807609 |
| 102 | ICK | 0.37354487 |
| 103 | MAP3K1 | 0.37072367 |
| 104 | SGK2 | 0.36941877 |
| 105 | CSNK1G1 | 0.36929204 |
| 106 | AKT2 | 0.36857892 |
| 107 | EGFR | 0.36171891 |
| 108 | PBK | 0.35910849 |
| 109 | MAP3K6 | 0.35055275 |
| 110 | MTOR | 0.34161207 |
| 111 | MAP3K13 | 0.33643412 |
| 112 | PRKCE | 0.33233410 |
| 113 | BCR | 0.31818282 |
| 114 | IRAK1 | 0.31595910 |
| 115 | CAMK4 | 0.31485245 |
| 116 | NTRK1 | 0.29877096 |
| 117 | PDK1 | 0.29746772 |
| 118 | SGK1 | 0.29580933 |
| 119 | HIPK2 | 0.29498528 |
| 120 | SGK223 | 0.27056882 |
| 121 | SGK494 | 0.27056882 |
| 122 | LATS2 | 0.26347030 |
| 123 | PRKCA | 0.24781025 |
| 124 | BMX | 0.24633673 |
| 125 | PRKACB | 0.23540754 |
| 126 | PAK3 | 0.22170459 |
| 127 | MAP2K2 | 0.20697449 |
| 128 | ABL1 | 0.19802190 |
| 129 | MAPK3 | 0.17378728 |
| 130 | CSNK1E | 0.17027343 |
| 131 | MAP4K1 | 0.16232114 |
| 132 | PRKCB | 0.15661306 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.52520161 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.75961029 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49885051 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.19761704 |
| 5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.16135333 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.10987587 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.70081536 |
| 8 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.68880947 |
| 9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.60669874 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.58881737 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48602070 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.34091101 |
| 13 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.12813870 |
| 14 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.09930885 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.06454692 |
| 16 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.02185436 |
| 17 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.00534450 |
| 18 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89674453 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89117176 |
| 20 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.87304867 |
| 21 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.84009327 |
| 22 | Histidine metabolism_Homo sapiens_hsa00340 | 1.82966985 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.82246365 |
| 24 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.80129437 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.75120158 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.69691158 |
| 27 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.68062436 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.65824335 |
| 29 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.60770269 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.59123375 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.57192849 |
| 32 | Retinol metabolism_Homo sapiens_hsa00830 | 1.56409070 |
| 33 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.53559355 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.52364184 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.49896185 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.47654021 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.43705847 |
| 38 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.36057437 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.34111574 |
| 40 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.32283606 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31174445 |
| 42 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25934546 |
| 43 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.21205716 |
| 44 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.20621003 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.20589512 |
| 46 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.20398693 |
| 47 | ABC transporters_Homo sapiens_hsa02010 | 1.17619851 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.13030042 |
| 49 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02992958 |
| 50 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00716844 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00673927 |
| 52 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96309036 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96159376 |
| 54 | Sulfur relay system_Homo sapiens_hsa04122 | 0.95345643 |
| 55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93885895 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93379678 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.89571113 |
| 58 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.84822439 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.77383151 |
| 60 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.74760594 |
| 61 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.67814514 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64449106 |
| 63 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63189921 |
| 64 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61389118 |
| 65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.50679888 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45330880 |
| 67 | Prion diseases_Homo sapiens_hsa05020 | 0.44045914 |
| 68 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43838366 |
| 69 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.33135210 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27229212 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.25694398 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.25475021 |
| 73 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24427561 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.23895134 |
| 75 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.20289515 |
| 76 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.20237286 |
| 77 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.16896149 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.11371685 |
| 79 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10217074 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02119940 |
| 81 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | -0.2707532 |
| 82 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2459609 |
| 83 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2409931 |
| 84 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.2295172 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2192714 |
| 86 | Amoebiasis_Homo sapiens_hsa05146 | -0.2184127 |
| 87 | Pertussis_Homo sapiens_hsa05133 | -0.2153869 |
| 88 | Bladder cancer_Homo sapiens_hsa05219 | -0.2132165 |
| 89 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | -0.1881388 |
| 90 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1773151 |
| 91 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1718809 |
| 92 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1718756 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1673846 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1662526 |
| 95 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1654141 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1595448 |
| 97 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.1524221 |
| 98 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.1454847 |
| 99 | Hepatitis C_Homo sapiens_hsa05160 | -0.1397127 |
| 100 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1290957 |
| 101 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1146323 |
| 102 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.0899288 |
| 103 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.0852811 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0798001 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0677593 |
| 106 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0525681 |
| 107 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0382921 |
| 108 | Mineral absorption_Homo sapiens_hsa04978 | -0.0329966 |
| 109 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0295730 |

